NCT00219063View on ClinicalTrials.gov

A Clinical Study to Compare an Aliskiren Based Hypertensive Regimen With a Ramipril Based One Followed by a Randomized Withdrawal.

PHASE3CompletedINTERVENTIONAL
Enrollment

844

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

March 31, 2006

Study Completion Date

March 31, 2006

Conditions
Hypertension
Interventions
DRUG

aliskiren

Trial Locations (1)

Unknown

Novartis Pharmaceuticals, East Hanover

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY